Prevalence of arterial hypertension and its morbidity in children and adolescents 3 years after renal transplantation with mycophenolate mofetil-based immunosuppression.
Jungraithmayr
T
T
Universitäts-Kinderklinik, Freiburg, Germany.
Staskewitz
A
A
Kirste
G
G
Böswald
M
M
Bulla
M
M
Burghard
R
R
Dippell
J
J
Greiner
C
C
Klare
B
B
Klaus
G
G
Leichter
H
H
Misselwitz
J
J
Patzer
L
L
Querfeld
U
U
Rascher
W
W
Tönshoff
B
B
Wiesel
M
M
Brandis
M
M
Zimmerhackl
L B
LB
D000293:Adolescent; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000453:epidemiology*; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D009017:Morbidity; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D015995:Prevalence; D012008:Recurrence; D012189:Retrospective Studies
D000959:Antihypertensive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine